Health & Nutrition

bg
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

Novo Nordisk offers diabetes drug Ozempic for less than...

Patients can pay $499 in cash per month for three dose sizes of Ozempic through...

bg
Why I Don’t Recommend Moringa Leaf Powder 

Why I Don’t Recommend Moringa Leaf Powder 

“Clearly, in spite of the widely held ‘belief’ in the health benefits of M. oleifera...

bg
Are Raw Mushrooms Safe to Eat? 

Are Raw Mushrooms Safe to Eat? 

Microwaving is probably the most efficient way to reduce agaritine levels in fresh...

bg
Candy giant Mars partners with biotech firm to gene-edit cocoa supply

Candy giant Mars partners with biotech firm to gene-edit...

The goal is to create cacao plants that can better withstand disease, heat and other...

bg
Eli Lilly shares drop after obesity pill shows modest late-stage trial results

Eli Lilly shares drop after obesity pill shows modest late-stage...

Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free...

bg
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

Eli Lilly hikes 2025 outlook, tops quarterly estimates...

Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped...

bg
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Doximity buys Pathway Medical for $63 million to help doctors...

Pathway's AI-powered clinical reference tool helps doctors answer questions about...

bg
Omada Health beats on revenue in first earnings report since IPO

Omada Health beats on revenue in first earnings report...

The company offers virtual care programs to support patients with chronic conditions.

bg
Is Moringa the Most Nutritious Food? 

Is Moringa the Most Nutritious Food? 

Does the so-called miracle tree live up to the hype? Moringa (Moringa oleifera)...

bg
Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results

Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly...

The results come as Pfizer and other drugmakers grapple with Trump's calls to lower...